2Cimola IN,Cheong AC.An assessment of a new diagnostic indirect enzyme immunoassay for the detection of anti-mycoplas-ma pneumoniae IgM.Am J Clin Pathol,1996:205-209.
1Casals C,Arias_Diaz J,Valino F,et al.Surfactant streng thens the inhibitor y effect of C_reactive protein on human lung macro p hage c y tokine release[].American Journal of Physiology Lung Cellular and Molecular Physiology.2003
4CotschlichEC.C_reactiveprotein,ahistoricaloverview[].Annals of the New York Academy of Sciences.1989
5RidkerP,HennekensC,BuringJ,etal.C_reactiveproteinandothermarkersofinflammationinthepredictionofcardiovas culardiseaseinwomen[].Netherlands Journal of Medicine.2000
6Siripataravanit S,Phaicharoen R,Termsetcharoen S,etal.Bacteria associated with acute exacerbations of chro-nic obstructive pulmonary disease requiring mechanicalventilation and antimicrobial management in Respirato-ry Care Unit of Central Chest Institute of Thailand[J].J Med Assoc Thai,2012,95(Suppl 8):S11-18.
7Okada T,Morozumi M,Tajima T,et al.Rapid Effective-ness of Minocycline or Doxycycline Against Macrolide-Resistant Mycoplasma pneumoniae Infection in a 2011Outbreak Among Japanese Children[J].Clin InfectDis,2012,55(12):1642-1649.
8Qu J, Gu L,Wu J, et al. Accuracy of IgM antibody testing,FQ-PCR and culture in laboratory diagnosis of acute infection by Mycoplasma pneumoniae in adults and adolescents with community-acquired pneu- monia[ J]. BMC Infectious Diseases,2013,13( 1 ) :172 - 173.
9Zasowski E, Butterfield JM, Mc-Nutt LA, et al. Relationship bet- ween time to clinical response and outcomes among Pneumonia Out- comes Research Team (PORT) risk class DI and 1V hospitalized patients with community-acquired pneumonia who received ceftriax- one and azithromycin [ J ]. Antimicrob Agents Chemoth, 2014,58 (7) :3804 -3813.
